002064:SZSEHuafon Chemical Co.,Ltd Analysis

The stock trades around 10.4 CNY, which sits above its DCF‑derived fair value, indicating a overvalued price. The trailing PE hovers near 30x while the forward PE has collapsed to about 14x, reflecting market expectations of earnings improvement but still a high valuation relative to peers. Margins are thin, with gross margin just over 12% and profit margin under 7%, and revenue has contracted roughly 10% year‑over‑year, underscoring a challenging growth backdrop. Nevertheless, the balance sheet is strong: cash balances exceed total debt by a wide margin and free cash flow remains positive, supporting a dividend yield near 2% with a payout ratio below 50%, which suggests dividend sustainability. The stock’s beta of roughly 0.16 points to minimal systematic risk, yet recent price swings have produced a 30‑day volatility above 60%, adding high volatility risk.
Technical indicators show a neutral trend: the 20‑day SMA lies just below the 50‑day SMA, and the price is hovering near the identified support around 10.4 CNY, while the MACD is in bearish territory and RSI sits in the low‑mid 30s, hinting at limited upside and potential downside pressure. Volume is rising, indicating continued market interest, but the upside‑downside estimate is slightly negative, reinforcing a cautious stance. Given the modest sector exposure to specialty chemicals, moderate regulatory and geographic risks, and a solid liquidity profile, the company appears positioned to weather short‑term headwinds while offering a stable dividend for income‑focused investors.